Amazon, Intel, Exxon Mobil rise premarket; Ford, Chevron fall

Investing.com — U.S. rose Friday, boosted by strong numbers from a couple of tech giants ahead of the release of key inflation data.

Here are some of the biggest premarket U.S. stock movers today:

• Amazon (NASDAQ:) stock rose 6.1% after the e-commerce giant reported third-quarter results that topped expectations as growth in its cloud business continued to stabilize and advertising growth jumped.

• Intel (NASDAQ:) stock rose 7% after the chip manufacturer delivered better-than-expected guidance for the current quarter after third-quarter earnings markedly beat analyst estimates amid signs PC demand has bottomed out.

• Ford (NYSE:) stock fell 3.4% after the auto giant withdrew its full-year results forecast due to “uncertainty” over the pending ratification of its deal with the United Auto Workers union.

• Exxon Mobil (NYSE:) stock rose 0.3% after the oil major posted a $9.1 billion third-quarter profit, an about 54% drop from record earnings a year ago but up from the prior quarter as oil prices recovered.

• JPMorgan (NYSE:) stock fell 0.9% after the lender said CEO Jamie Dimon would sell a portion of his stock holdings in the bank in 2024 for financial diversification and tax planning.

• Chevron (NYSE:) stock fell 2% after the oil giant reported a fall in third-quarter profit despite higher oil prices, days after agreeing to buy smaller U.S. rival Hess (NYSE:) for $53 billion.

• Natwest (NYSE:) stock fell 10% after the Financial Conduct Authority said it had identified potential “regulatory breaches” in the U.K.-based lender’s handling of a decision to close former Brexit party leader Nigel Farage’s accounts.

• Sanofi (NASDAQ:) ADRs fell 18% after the French drugmaker dropped its 2025 profit target under a plan to list its consumer healthcare business, while lifting its development spending plans.

• Enphase Energy (NASDAQ:) stock slumped 19% after the solar inverter maker missed quarterly revenue forecasts and offered full-year guidance well below expectations.

• AbbVie (NYSE:) stock rose 1.6% after the pharmaceutical company raised its annual profit forecast after beating quarterly earnings estimates, helped by a lower-than-feared drop in sales of its blockbuster arthritis drug, Humira, and strong demand for newer drugs.
• Colgate-Palmolive (NYSE:) stock rose 1.1% after the consumer goods company raised its annual organic sales and profit forecasts for a third time this year, betting on price hikes and steady demand for its self-care and pet nutrition products.